BRCA1 and breast carcinoma: The observation that BRCA1 mutation carriers who are older or post-menopausal at the time of diagnosis of breast cancer are more likely to have an ER+ breast cancer may help to define a population of BRCA1 mutation carriers for whom estrogen-modifying agents will be particularly effective.